𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differential Expression of DNA Topoisomerase IIα and IIβ Genes between Small Cell and Non-small Cell Lung Cancer

✍ Scribed by Syahruddin, Elisna ;Oguri, Tetsuya ;Takahashi, Toshiaki ;Isobe, Takeshi ;Fujiwara, Yasuhiro ;Yamakido, Michio

Book ID
108581614
Publisher
Wiley (Blackwell Publishing)
Year
1998
Tongue
English
Weight
92 KB
Volume
89
Category
Article
ISSN
0910-5050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amplification of the topoisomerase ii α
Amplification of the topoisomerase ii α gene in a non-small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase ii α and β loci in normal tissue
✍ W. Nicol Keith; Robert Brown; K. B. Tan 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

n sylvan la (K. B.T.) DNA was prepared from normal tissue and I9 lung cancer cell lines. Using probes which detect restriction fragment length polymorphisms at both the topoisomerase II u and p loci, heterozygosity was detected at a frequency of 0. I 7 and 0.37 for the

Differential expression of matrix metall
Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer
✍ Thomas, Pascal; Khokha, Rama; Shepherd, Frances A.; Feld, Ronald; Tsao, Ming-Sou 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

In a comprehensive immunohistochemical study of the expression of ten metalloproteinases (MMPs) and their four inhibitors (TIMPs) in 115 non-small cell lung carcinomas (NSCLCs), the ®ndings have been correlated with the histological and clinical features of the tumours. All MMPs and TIMPs were expre

Comparison of DNA topoisomerase IIα expr
Comparison of DNA topoisomerase IIα expression in small cell and nonsmall cell carcinoma of the lung: In search of a mechanism of chemotherapeutic response
✍ Donald G. Guinee Jr.; Joseph A. Holden; John R. Benfield; Madeline L. Woodward; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

## BACKGROUND. Small cell carcinoma of the lung (SCLC) is distinguished from nonsmall cell carcinoma (NSCLC) by its exquisite initial sensitivity to chemotherapy. Antineoplastic drugs effective against SCLC include doxorubicin, etoposide, and others. Recently, the molecular target of these drugs h